538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp

by Joseph Sacco, Richard Carvajal, Omid Hamid, Marcus Butler, Jason Luke, Takami Sato, Paul Nathan, Jessica Hassel, Douglas Johnson, Leonel Hernandez-Aya, Alexander Shoushtari, Josep Piulats, Enrique Espinosa, Serge Leyvraz, Alexandra Ikeguchi, Matthew Rioth, Chris Holland, Michelle McCully, Shaad Abdullah
Published 2021-11-01

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma

by Jessica C Hassel, Alexander N Shoushtari, Omid Hamid, Takami Sato, Paul Nathan, Marcus O Butler, Jason J Luke, Richard D Carvajal, Leonel Hernandez-Aya, Douglas B Johnson, Laura Collins, Enrique Espinosa, Joseph J Sacco, Serge Leyvraz, Alexandra Ikeguchi, Matthew Rioth, Chris Holland, Josep M Piulats
Published 2024-06-01

Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy

by Carol M. Amato, Jennifer D. Hintzsche, Keith Wells, Allison Applegate, Nicholas T. Gorden, Victoria M. Vorwald, Richard P. Tobin, Kelsey Nassar, Yiqun G. Shellman, Jihye Kim, Theresa M. Medina, Matthew Rioth, Karl D. Lewis, Martin D. McCarter, Rene Gonzalez, Aik-Choon Tan, William A. Robinson
Published 2020-07-01